FDA inspection
Pfizer Asia Manufacturing Pte Ltd.: FDA inspection ending Mar 1, 2013
FDA inspection 825350 · No Action Indicated (NAI) · Singapore
Key facts
| Inspection ID | 825350 |
|---|---|
| Firm | Pfizer Asia Manufacturing Pte Ltd. |
| FEI number | 3003901862 |
| Address | 31 Tuas South Avenue 6 |
| City | Singapore |
| Country | Singapore |
| Fiscal year | 2013 |
| Inspection end date | Mar 1, 2013 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data